Skip to main content
Pokarna Ltd. logo

Pokarna Ltd. — Investor Relations & Filings

Ticker · POKARNA ISIN · INE637C01025 LEI · 335800RJUDMUDQD5IB11 BSE.NS Manufacturing
Open in API
Filings indexed 555 across all filing types
Latest filing 2024-11-12 Regulatory Filings
Country IN India
Listing BSE.NS POKARNA

About Pokarna Ltd.

https://www.pokarna.com

Pokarna Ltd. specializes in the processing of natural granite and the manufacture of engineered quartz surfaces. The company operates multiple captive granite quarries, extracting a diverse range of colors and textures for global architectural applications. Its granite division utilizes advanced processing technologies to produce high-quality slabs and tiles. Through its subsidiary, Pokarna Engineered Stone Limited, the company produces premium quartz surfaces under the brand name Quantra. These surfaces are manufactured using patented Bretonstone technology, which provides high durability, non-porous qualities, and aesthetic versatility. The company serves an international clientele, providing surfacing solutions for residential and commercial interiors, including countertops, flooring, and wall cladding. Its business model is characterized by vertical integration, spanning from raw material extraction to the distribution of finished architectural products.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2024-11-12 English
Outcome of Board Meeting
Regulatory Filings
2024-11-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an official communication from Pokarna Limited to stock exchanges (BSE and NSE) informing about the schedule of an investors conference call to discuss the company's Q2 FY25 earnings results. It includes details such as date, time, dial-in numbers, and registration information for the call. The document does not contain actual financial data or analysis but serves as an announcement of the upcoming earnings call event. According to the classification rules, such a document is best categorized as a Call Transcript (CT) if it contained the full transcript, but since this is only an announcement of the call schedule, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories. The document length is short and it is not the earnings release itself, so it is not ER. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-11-04 English
General Updates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the rescission of proposed administrative reviews for Anti-Dumping and Countervailing Duty orders by the US Department of Commerce for a subsidiary of the company. It is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content is a regulatory announcement informing the exchanges and public about a specific regulatory development affecting the company. The document is short (2261 characters) and does not contain financial statements, management discussion, or detailed financial data. It is not a report itself but an announcement of a regulatory event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-11-04 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the final results of an anti-dumping duty administrative review for the fiscal period June 1, 2022, through May 31, 2023. It references a regulatory compliance requirement under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The document is an announcement of the final results of a regulatory review, not a full financial report or audit. It is short (1854 characters) and serves to inform the exchanges and public about the outcome of the anti-dumping duty review. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-11-04 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2024-10-29 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.